Free Trial

Lyell Immunopharma (LYEL) SEC Filings & 10K Form

Lyell Immunopharma logo
$11.30 -0.03 (-0.22%)
As of 09:50 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Recent Lyell Immunopharma SEC Filings

DateFilerForm TypeView
07/30/2025
11:15 PM
Lyell Immunopharma (Filer)
Form EFFECT
07/29/2025
8:23 PM
ARCH Venture Fund XIII, L.P. (Reporting)
ARCH Venture Partners XIII, L.P. (Reporting)
ARCH Venture Partners XIII, LLC (Reporting)
BERNS PAUL L (Reporting)
Burow Kristina (Reporting)
CRANDELL KEITH (Reporting)
GILLIS STEVEN (Reporting)
Lyell Immunopharma (Issuer)
NELSEN ROBERT (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/29/2025
8:25 PM
ARCH Venture Fund IX Overage, L.P. (Reporting)
ARCH Venture Fund IX, L.P. (Reporting)
ARCH Venture Partners IX Overage, L.P. (Reporting)
ARCH Venture Partners IX, L.P. (Reporting)
ARCH Venture Partners IX, LLC (Reporting)
BYBEE CLINTON (Reporting)
CRANDELL KEITH (Reporting)
Lyell Immunopharma (Issuer)
NELSEN ROBERT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/25/2025
7:05 AM
Lyell Immunopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/18/2025
3:20 PM
Lyell Immunopharma (Filer)
Form S-3
Registration statement under Securities Act of 1933  
06/26/2025
3:07 PM
Lyell Immunopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/17/2025
7:49 AM
Lyell Immunopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2025
4:48 PM
Bachleda Mark (Reporting)
Lyell Immunopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2025
4:38 PM
Lyell Immunopharma (Issuer)
Shook David (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/11/2025
4:40 PM
Lyell Immunopharma (Issuer)
Meltz Mark A (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/11/2025
4:42 PM
Bachleda Mark (Reporting)
Lyell Immunopharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/11/2025
4:45 PM
Lyell Immunopharma (Issuer)
Shook David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2025
4:47 PM
Lyell Immunopharma (Issuer)
Meltz Mark A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2025
3:23 PM
Lyell Immunopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/19/2025
5:41 PM
Lyell Immunopharma (Issuer)
Ramachandra Sumant (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2025
5:43 PM
Lyell Immunopharma (Issuer)
NABEL ELIZABETH G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2025
5:45 PM
BRAWLEY OTIS W (Reporting)
Lyell Immunopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2025
5:47 PM
FRIEDMAN CATHY (Reporting)
Lyell Immunopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2025
5:48 PM
Lyell Immunopharma (Issuer)
RIEFLIN WILLIAM JL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2025
5:50 PM
Klausner Richard (Reporting)
Lyell Immunopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2025
3:39 PM
Lyell Immunopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2025
3:41 PM
Lyell Immunopharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/10/2025
3:55 PM
Lyell Immunopharma (Filer)
Form PRE 14A
04/02/2025
2:46 PM
BRAWLEY OTIS W (Reporting)
Lyell Immunopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2025
4:01 PM
Lyell Immunopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/25/2025
5:46 PM
Lyell Immunopharma (Issuer)
Ramachandra Sumant (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
7:07 PM
Klausner Richard (Reporting)
Lyell Immunopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
6:01 PM
Lyell Immunopharma (Issuer)
Newton Charles W. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
5:59 PM
Lyell Immunopharma (Issuer)
Seely Lynn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
3:52 PM
Lyell Immunopharma (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/26/2025
6:27 PM
Lee Gary K. (Reporting)
Lyell Immunopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2025
6:29 PM
Lyell Immunopharma (Issuer)
Newton Charles W. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2025
6:31 PM
Hill Stephen J. (Reporting)
Lyell Immunopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2025
6:33 PM
Lyell Immunopharma (Issuer)
Seely Lynn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2025
6:36 PM
Lang Matthew (Reporting)
Lyell Immunopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
12:23 PM
BlackRock, Inc. (Filed by)
Lyell Immunopharma (Subject)
Form SCHEDULE 13G/A
01/24/2025
3:39 PM
Lyell Immunopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2025
8:10 AM
Lyell Immunopharma (Filer)
Form 8-K/A
12/09/2024
8:03 PM
Lyell Immunopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/09/2024
7:39 AM
Lyell Immunopharma (Filer)
Form 424B5
12/05/2024
11:15 PM
Lyell Immunopharma (Filer)
Form EFFECT
BREAKING: The House just passed 3 pro-crypto bills! (Ad)

THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here.

Discover the under-the-radar project I believe will skyrocket as a result.
11/29/2024
3:19 PM
Lyell Immunopharma (Filer)
Form S-3
Registration statement under Securities Act of 1933  
11/26/2024
3:05 PM
Lyell Immunopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2024
12:30 PM
Lyell Immunopharma (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/01/2024
3:54 PM
Lyell Immunopharma (Issuer)
Ramachandra Sumant (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/01/2024
3:56 PM
Lyell Immunopharma (Issuer)
Ramachandra Sumant (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/31/2024
5:00 PM
Foresite Capital Fund IV, L.P. (Filed by)
Lyell Immunopharma (Subject)
Form SC 13G
10/31/2024
3:45 PM
Lyell Immunopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/24/2024
3:06 PM
Lyell Immunopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:LYEL) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners